The U.S. government agency Medical Command awarded a $444,009.20 firm fixed price purchase order contract to Sebia, Inc., a global leader in automated electrophoresis technologies. The contract is for CAPILLARYS HEMOGLOBIN and does not have a set-aside designation. Sebia, Inc. provides advanced medical diagnostic equipment, reagents, consumables, and clinical testing services to federal healthcare agencies. The contract has an ultimate completion date of September 30, 2017. Sebia, Inc. holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and Department of Defense (DoD) to support their diagnostic testing needs across various regions and agencies.